Delivery Order SPE2DB25D7068-SPE2DB25FTVCE
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product, with a ceiling value of $89,102.25 and a completion date of January 7, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 200 MG/1.14 ML PEN 1.14ML, a specialty pharmaceutical product. The contract has a ceiling value of $3,407.93 and a period of performance through October 11, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a ceiling value of $17,478.45 and is a firm fixed-price delivery order that runs through November 7, 2024. The contract does not have a set-aside designation, indicating open competition. As an Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product, with a ceiling value of $52,933.78 and a performance period through December 9, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,709.46 and is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to support federal healthcare programs. The contract is a firm-fixed-price delivery order that is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with an ultimate completion date of August 27, 2024. The contract has a ceiling value of $7,554.01 and is a firm fixed-price delivery order. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $7,793.76, is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and runs through November 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product, to support military healthcare programs. The contract has a ceiling value of $17,289.27 and an ultimate completion date of January 7, 2025. The contract is a firm fixed-price delivery order and does not have a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $16,521.53 and is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract is for a firm fixed price and has an ultimate completion date of January 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication, with a ceiling value of $17,586.54 and a period of performance through October 9, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen, through its Corporate Office division, has been awarded multiple federal contracts and Indefinite Delivery...